Vascular endothelial growth/permeability factor (VEG/PF) has an established role in angiogenesis, however, the regulation of placental VEG/PF expression during primate pregnancy is incompletely understood. A temporal study was conducted in baboons to determine the effect of acute administration of estradiol on the expression of VEG/PF by cells of the villous placenta. VEG/PF mRNA levels were determined by reverse transcriptionpolymerase chain reaction in isolated placental cell fractions of baboons after acute i.v. and i.m. administration of estradiol. Within 2 h of estradiol treatment, VEG/PF mRNA (attomoles/ micrograms total RNA) increased within villous cytotrophoblasts to a level (mean ؎ SEM, 12 612 ؎ 2419) that was almost 2-fold greater (P Ͻ 0.05) than in untreated controls (6810 ؎ 1368). Cytotrophoblast VEG/PF mRNA levels remained elevated (P Ͻ 0.01) 6 h after estradiol treatment (15 006 ؎ 506), but were not different from controls 18 h after estradiol administration. VEG/ PF mRNA levels in whole villous tissue also were greater 6 h (12 667 ؎ 2284, P Ͻ 0.05) and 18 h (16 080 ؎ 3816, P Ͻ 0.01) after estradiol treatment than in untreated animals (3380 ؎ 594). In contrast, VEG/PF mRNA levels in cells of the inner villous core were not altered by estradiol treatment. Expression of both the VEG/PF 121 and VEG/PF 165 mRNA species appeared to increase in the placenta 6 h after estradiol treatment of baboons. We propose that estrogen regulates VEG/PF expression within the placenta in a cell-specific manner, providing a paracrine system to promote vascularization of the villous placenta during the first half of primate pregnancy.
INTRODUCTION
With advancing primate pregnancy, an extensive vascular network develops within the villous placenta by in situ differentiation of fetal mesenchymal cells into blood vessels (i.e., vasculogenesis) and proliferation of existing vessels (i.e., angiogenesis). Relatively little is known, however, about the factors involved in regulating placental vascularization during primate pregnancy (see [1, 2] for reviews). Vascular endothelial growth/permeability factor (VEG/PF) has a well established role in angiogenesis [3] , including the induction of microvascular permeability an early step, which appears critical to angiogenesis [4] . VEG/ PF is expressed as five isoforms, generated by alternate splicing of the mRNA to yield proteins of 121, 145, 165, 189, and 206 amino acids. In other tissues, chronic estrogen administration in vivo increased VEG/PF expression (e.g., in the rat [5] , sheep [6] , and baboon [7] uterus).
Using the baboon as a nonhuman experimental model, we recently showed that placental VEG/PF mRNA levels and the level of vascularization increased in association with the rise in serum estrogen levels that occur with advancing stages of pregnancy [8] . Moreover, chronically elevated serum estradiol levels early in baboon pregnancy increased placental villous trophoblast VEG/PF mRNA expression and neovascularization of the placenta (E.D. Albrecht, V.A. Robb, and G.J. Pepe, unpublished results). Therefore, we suggested that estrogen has an important role in establishing the new vascular system within the placenta during primate pregnancy and that VEG/PF mediates this process. However, because long-term administration of steroid hormones may result in cellular differentiation, it is not known whether or not the increase in placental VEG/ PF expression induced by estrogen represents direct effects on VEG/PF mRNA expression. To address this possibility, a temporal study was conducted in baboons to determine the effect of acute administration of estradiol on the expression of VEG/PF by isolated cell fractions of the villous placenta in early gestation when endogenous estradiol levels are low.
MATERIALS AND METHODS

Animals
Female baboons (Papio anubis) weighing 13-18 kg were individually housed in large aluminum and stainless steel primate cages, and received high-protein monkey chow twice daily, fresh fruit, and vitamins daily, and water ad libitum. Females were paired with male baboons for 5 days at the anticipated time of ovulation as estimated by menstrual cycle history and turgescence of external sex skin. The first day of gestation was designated as 2 days preceding the day of detumescence.
To assess the temporal effect of acute estradiol administration on placental VEG/PF expression on Day 54 of gestation (length of gestation is 184 days), baboons were briefly sedated with ketamine HCl (10 mg/kg body weight, i.m.) and treated with 100 g of 17␤-estradiol in 1.0 ml of 5% ethanol:saline administered as a bolus via an antecubital vein to achieve a rapid increase in blood estrogen levels and 500 g estradiol benzoate i.m. in 0.5 ml of sesame oil to achieve a sustained increase in blood estrogen levels throughout the study period. Baboons were then anesthetized with halothane, and placentas were obtained via cesarean delivery after no treatment or 6 h after ethanol:saline vehicle treatment (results of n ϭ 8 baboons combined, because results were similar in untreated and vehicle-treated animals), or 2 h (n ϭ 6), 6 h (n ϭ 6), or 18 h (n ϭ 5) after estradiol treatment. Blood samples (2 ml) were obtained throughout the study period from a maternal saphenous vein, and serum estradiol levels were determined by RIA using an automated chemiluminescent immunoassay system (Immulite; Diagnostic Products Corp, Los Angeles, CA), as described previously [9] .
Baboons were cared for and used strictly in accordance with U.S. 
Placental Tissue
Randomly selected sections (approximately 4 mm 3 each) of villous tissue were excised from each placenta and stored frozen in liquid nitrogen for mRNA analysis. From the majority of the remaining placental villous tissue, enriched fractions of cytotrophoblasts and cells of the inner villous core were obtained as previously described by our laboratory [10] and by Kliman et al. [11] and used for quantification of VEG/PF mRNA levels by competitive reverse transcription-polymerase chain reaction (RT-PCR). Briefly, villous tissue was minced in Hanks balanced salt solution (HBSS; Life Technologies Inc., Gaithersburg, MD) and digested in HBSS containing 0.1% hyaluronidase (type I-S; Sigma Chemical, St. Louis, MO), 0.1% collagenase (Type H; Sigma Blend), and 0.01% deoxyribonuclease I (1680 Kunitz units/mg; Sigma). Enriched cell fractions were then isolated by 5%-70% Percoll (Pharmacia Fine Chemicals, Piscataway, NJ) gradient centrifugation at 1200 ϫ g. Kliman et al. [11] and we (unpublished data) have previously shown that highly enriched cytokeratin-positive cytotrophoblast and ␣-antichymotrypsin-positive inner villous cell fractions were obtained from the placenta using the latter cell isolation procedure. Although an enriched fraction of syncytiotrophoblast was also obtained, sufficient RNA was not isolated for competitive RT-PCR analysis of VEG/ PF mRNA.
RT-PCR of VEG/PF
The mRNA levels for VEG/PF were quantified by the competitive RT-PCR assay established by Riedy et al. [12] , as modified by our laboratory [13] . Placental cell fractions were homogenized in 4 M guanidine isothiocynate, layered over 5.7 M cesium chloride, and total RNA was pelleted by centrifugation.
Oligonucleotide primers were designed (Invitrogen Life Technologies, Carlsbad, CA) from selected regions within the human VEG/PF cDNA sequence [14] : Because primers 3 and 4 are upstream of the alternative splice site that generates the different isoforms of VEG/PF, a single 323-base pair (bp) PCR product was generated. A homologous competitive reference standard (CRS) was prepared using primers 1 and 2 and had a 67 bp deletion (length, 256 bp) compared with wild-type target mRNA. Total RNA (3.2 g) from baboon placenta was reverse transcribed in a reaction mixture containing 1 mM deoxy(d)NTPs (Invitrogen), 1 mM dithiothreitol, 200 U Superscript RNase H-reverse transcriptase (RT; Invitrogen), 40 U RNAguard ribonuclease inhibitor (Pharmacia Biotech, Piscataway, NJ), 1ϫ RT buffer, and 250 ng random primers (Invitrogen). After 60 min, the RT mixture was incubated at 70ЊC for 15 min and 5 l of the RT mixture added to a PCR reaction mixture containing 0.2 mM dNTPs (Invitrogen), 1ϫ PCR buffer, 1.25 U cloned Thermus aquaticus DNA polymerase (Amplitaq, Perkin-Elmer Corp/Cetus, Norwalk, CT) and 20 pmol each of primers 1 and 2. PCR was performed in a programmable thermal cycler (MJ Research Inc., Cambridge, MA) and samples were amplified in 25 sequential cycles at 94ЊC for 1 min, 60ЊC for 1 min, and 72ЊC for 2 min, with a final extension at 72ЊC for 5 min. The PCR mixture was fractionated by electrophoresis in a 2% agarose gel and visualized with ethidium bromide. The amplified product containing a sequence for the T7 polymerase, as well as the designated deletion, was gel purified using a Qiaex DNA gel extraction kit (Qiagen, Inc., Valencia, CA) . The CRS was synthesized from 150 ng of cDNA template using the MEGAscript T7 in vitro transcription kit (Ambion, Inc., Austin, TX) and quantitated via UV absorption spectrophotometry at an optical density of 260 nm.
To quantify VEG/PF mRNA, a constant amount of total RNA (75-300 ng) was added to an RT mixture containing 3-fold serial dilutions of the VEG/PF CRS (5400-200 attomoles). Negative controls, in which either the RT enzyme or RNA was omitted from the RT reaction, were performed to test for any contaminating pseudogene or genomic DNA. Upon completion of the RT, 5 l of the RT reaction was added to a PCR mixture containing 20 pmol each of primers 3 and 4 (26 cycles). The PCR products were fractionated in a 2% agarose gel containing ethidium bromide, visualized with a UV transilluminator, and photographed using type 665 positive/negative film (Polaroid Corp, Cambridge, MA). Negatives were scanned using a model 620 Video Densitometer and 1-D Analyst II data analysis software (Bio-Rad Laboratories, Hercules, CA). The intensity of amplified product was represented as the relative area under each sample band. The logarithm (log) of the ratio of VEG/PF CRS area to VEG/PF target area was plotted as a function of the concentration of VEG/PF CRS added to each PCR reaction. The concentration of VEG/PF target mRNA was determined where the ratio of the log of CRS and target was equal to 0 (i.e., the equivalence point).
Northern Blot Analysis of VEG/PF
Expression of the mRNAs for the VEG/PF species were determined by Northern blot analysis as previously described in our laboratory [15] . Poly(A) ϩ -enriched RNA was prepared by centrifugation of 500-750 g total RNA from whole villous tissue over columns of oligo (deoxythymidine) cellulose (Pharmacia, Piscataway, NJ). Approximately 4 g of poly(A) ϩ -enriched RNA was denatured in 50% formamide, 2.2 M formaldehyde, and 20 mM 3-[N-morpholino] propane sulfonic acid (MOPS) pH 7.0, and size-fractioned by electrophoresis in 1.0% agarose gel containing 0.6 M formaldehyde and 20 mM MOPS pH 7.0. RNA was transferred overnight by capillary action in 10ϫ saline-sodium citrate (SSC; 1.5 M NaC1-0.15 M sodium citrate-2H 2 O pH 7.0) onto a nylon membrane (Gene Screen; Dupont-New England Nuclear Corp, Boston, MA). RNAcontaining membranes were UV cross-linked, baked in a vacuum oven at 80ЊC for 2 h, and prehybridized in buffer containing 50% formamide, 0.1% polyvinylpyrrolidone, 0.1% BSA, 0.1% Ficoll, 2.5ϫ SSPE (0.375 M NaCl, 0.025 M NaH 2 PO 4 -H 2 O, 0.0025 M EDTA), 1.0% SDS, 10% dextran sulfate, and denatured salmon sperm DNA (100 g/ml) for 24 h at 42ЊC prior to addition of probe. The cDNA for human VEG/PF was provided by the Collaborations Program of Genetech (South San Francisco, CA). The human cDNA for ␤-actin (No. 65128) was obtained from American Type Culture Collection (Manassas, VA). The cDNAs were labeled with 50 Ci [␣-32 P] dCTP (3000 Ci/mmol, Amersham Corp., Arlington Heights, IL) to a specific activity of approximately 10 9 dpm/g DNA using the Random-Primed DNA labeling kit (Boehringer Mannheim, Indianapolis, IN). Hybridization was performed in fresh buffer at 42ЊC for 21-24 h with approximately 10 6 cpm/ml [ 32 P] cDNA probe. After hybridization, membranes were washed twice at room temperature for 10 min in 2ϫ SSC, then at 65ЊC for 20 min in 2ϫ SSC, 1% SDS, followed by room temperature wash in 0.1ϫ SSC. Membranes were exposed to Kodak X-AR film (Eastman Kodak, Rochester, NY) at Ϫ80ЊC. After exposure, membranes were stripped before rehybridization. Intensities of blots were analyzed by densitometric autoradiographic scanning using a Model 620 Video Densitometer and 1-D Analyst II software (Bio-Rad). The relative intensities of the mRNA transcripts for VEG/PF were related to those of ␤-actin to determine specific effects on expression.
Statistics
Data are expressed as the mean Ϯ SEM. Placental cell VEG/PF mRNA levels in baboons were analyzed by two-way analysis of variance (AN-OVA; 3 ϫ 4 factorial design).
RESULTS
Serum Estradiol
Mean Ϯ SEM maternal peripheral serum estradiol levels in baboons increased from 0.12 Ϯ 0.02 ng/ml at Time 0 to a peak of 1.19 Ϯ 0.52 ng/ml at 15 min after acute i.v. and i.m. injections of estradiol (Fig. 1) . Serum estradiol then declined after 1 h to a plateau at which levels at 2 h (0.48 Ϯ 0.02 ng/ml), 6 h (0.44 Ϯ 0.16 ng/ml), and 18 h (0.55 Ϯ Figure 2 shows a representative quantitative analysis of VEG/PF mRNA levels by competitive RT-PCR in cytotrophoblasts obtained from baboons untreated and 2 h after treatment with a bolus of estradiol. The expected 323-bp VEG/PF target product and the 256-bp VEG/PF CRS product generated by PCR are shown in Figure 2A . No PCR product was detected when either RNA or RT enzyme were omitted from the reaction (data not shown). The slopes of the log of CRS to target areas plotted as a function of increasing amounts of CRS were similar for RNA obtained from untreated and estrogen-treated cytotrophoblasts (Fig.  2B ), indicating no difference in amplification efficiency.
VEG/PF mRNA
Cytotrophoblasts were the major source of VEG/PF mRNA in the villous placenta of untreated baboons on Day 54 of gestation (Fig. 3) , as we have previously shown throughout pregnancy [8] . VEG/PF mRNA levels determined in cytotrophoblasts of baboons treated with ethanol: saline vehicle were similar to values in untreated control baboons (data not shown). Within 2 h of estradiol treatment, VEG/PF mRNA increased within the villous cytotrophoblast fraction to a level (mean Ϯ SEM ϭ 12 613 Ϯ 2419 attomoles/g total RNA) that was almost 2-fold greater (P Ͻ 0.05) than that in untreated controls (6810 Ϯ 1368 attomoles/g total RNA). Cytotrophoblast VEG/PF mRNA levels remained elevated (P Ͻ 0.01) 6 h after estrogen treatment (15 006 Ϯ 506), but were not significantly different from control 18 h after estradiol administration. Corresponding to the findings in cytotrophoblasts, VEG/PF mRNA levels in whole villous tissue were greater 6 h (12 667 Ϯ 2284 attomoles/g total RNA, P Ͻ 0.05) and 18 h (16 080 Ϯ 3816, P Ͻ 0.01) after estradiol treatment than in untreated controls (3380 Ϯ 594). In contrast, VEG/ PF mRNA levels in cells of the inner villous core were not significantly changed at any of the time points after acute estrogen treatment (Fig. 3) compared to untreated baboons (3462 Ϯ 642 attomoles/g total RNA).
To confirm that there were no changes in a constitutively expressed cellular RNA, the levels of 18S rRNA in the various placental cell fractions were semiquantified by RT-PCR using specific 18S rRNA primers. The mean levels of 18S rRNA were similar on Day 54 of gestation in baboons untreated or treated with estradiol (data not shown), suggesting that total RNA levels were not affected by treatment.
To determine which isoform mRNA might be affected by estradiol treatment, we utilized Northern blot analysis. The mRNA for VEG/PF 121 and VEG/PF 165 were the predominate isoforms expressed in the baboon placenta on Day 54 of gestation (Fig. 4A) . Expression of both the VEG/ PF 121 and VEG/PF 165 mRNA species appeared to increase in the placenta 6 h after estradiol treatment of baboons (Fig.  4B ).
DISCUSSION
The results of the present study show that VEG/PF mRNA levels in placental villous cytotrophoblasts were rapidly elevated within 2 h of acute estradiol administration to baboons in early gestation. The increase in placental VEG/PF appeared to reflect up-regulation of the VEG/PF 121 and VEG/PF 165 species, which are the most abundantly expressed isomers, and which are believed to mediate early aspects of angiogenesis such as increased microvascular permeability [4] . We also reported recently that placental villous cytotrophoblast VEG/PF mRNA levels were increased with advancing baboon pregnancy, coinciding with the rise in serum estradiol levels [8] and early in baboon pregnancy by prematurely and chronically elevating estrogen levels (E.D. Albrecht, V.A. Robb, and G.J. Pepe, unpublished results). Moreover, placental VEG/PF mRNA levels were decreased by suppressing estrogen levels after administration of an aromatase inhibitor early in baboon gestation, an effect prevented or reversed by concomitant treatment with estradiol (E.D. Albrecht, V.A. Robb, and G.J. Pepe, unpublished results). Systematic deletions of the VEG/PF promoter have identified upstream sequences critical for estrogen receptor-activated gene transcription [16, 17] . Also, we and others have demonstrated that estrogen receptor ␣ and ␤ are expressed within human [18, 19] and baboon [20] villous trophoblasts. Although VEG/PF protein levels were not quantified in the present study, both VEG/ PF mRNA and protein were expressed extensively by villous cytotrophoblasts in human [21] [22] [23] [24] and baboon ( [8] and E.D. Albrecht, V.A. Robb, and G.J. Pepe, unpublished results). Collectively, these observations are consistent with the concept that estrogen acts to up-regulate expression of VEG/PF by villous cytotrophoblasts during primate pregnancy. Therefore, estrogen appears to exert a central important regulatory effect on VEG/PF expression within the placenta, as previously demonstrated within the uterine endometrium of the rat [5] , sheep [6] , baboon [7, 25] , and human [26] . It remains to be determined, however, whether the rapid stimulatory effect of estrogen on placental trophoblast VEG/PF mRNA levels shown in the present study reflected transcriptional events in VEG/PF synthesis.
The regulatory effect of estrogen on placental VEG/PF mRNA expression appeared to be specific for villous cytotrophoblasts, because VEG/PF mRNA levels within an enriched fraction of cells of the placental inner villous compartment were unaltered by acute administration of estradiol. Moreover, although we could not measure VEG/PF mRNA levels within placental syncytiotrophoblasts in baboons of the present study, we have shown previously that VEG/PF mRNA expression in syncytiotrophoblast was very low and not changed despite the rise in estrogen typical of advancing stages of baboon pregnancy [8] . In addition, cytotrophoblast VEG/PF mRNA levels were not altered by suppressing estrogen production by administration of aromatase inhibitor in the second half of baboon pregnancy (E.D. Albrecht, V.A. Robb, and G.J. Pepe; unpublished observations). Consequently, it appears that estrogen regulates VEG/PF expression within the placenta in a celland developmental-specific manner during primate pregnancy.
In addition to estrogen, other factors, notably oxygen levels [1, 27, 28] , have an important role in regulating VEG/PF expression. Thus, placental VEG/PF expression is up-regulated by hypoxia [21, 28, 29] and down-regulated by hyperoxia [28] . Based on our recent report ( [8] and E.D. Albrecht, V.A. Robb, and G.J. Pepe, unpublished results), the studies of others, and the present study, we propose as illustrated in Figure 5 that a paracrine system involving estrogen and other factors and different cell types exists to promote vascularization within the developing placenta. We postulate that estrogen produced by the syncytiotrophoblast [30] , and possibly other factors such as oxygen and nitric oxide of trophoblast or stromal origin (or a combination of these) (reviewed in [2] ), regulate in a paracrine manner the expression of VEG/PF by immediately adjacent villous cytotrophoblasts and possibly other cell components, which in turn, promotes angiogenesis within the fetal stromal compartment during primate pregnancy. In summary, VEG/PF mRNA levels in placental villous cytotrophoblasts were elevated rapidly within 2 h of acute estradiol administration to baboons in early pregnancy. We propose that estrogen regulates VEG/PF expression in a cell-and developmental-specific manner providing a paracrine system to promote vascularization of the villous placenta during the first half of primate pregnancy.
